As a consequence, after the initial useas antihypertensive drugs [2], ACE-inhibitors (ACE-I) rapidly became afundamental tool also in treating congestive heart failure, left ventriculardysfunction after myocardial infarction, diabetic and nondiabetic nephropathies[2–4]. This evidence concerns the gene ACE and myocardial infarction.